{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:08:11Z","timestamp":1791648491481,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10620-025-09593-9","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:54:54Z","timestamp":1764680094000},"page":"1953-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis"],"prefix":"10.1007","volume":"71","author":[{"given":"Omar","family":"Al Ta\u2019ani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqr","family":"Alsakarneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasma","family":"Shaukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi F.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"9593_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2036.2004.02046.x","volume":"20","author":"J Eaden","year":"2004","unstructured":"Eaden J. Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20:24\u201330. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02046.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9593_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cgh.2020.08.015","volume":"19","author":"B Lo","year":"2021","unstructured":"Lo B, Zhao M, Vind I, Burisch J. The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2021;19:1117-1138.e19. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.015.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cgh.2024.03.032","volume":"22","author":"JE Axelrad","year":"2024","unstructured":"Axelrad JE, Hashash JG, Itzkowitz SH. AGA clinical practice update on management of inflammatory bowel disease in patients with malignancy: commentary. Clin Gastroenterol Hepatol. 2024;22:1365\u20131372. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.032.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","volume":"80","author":"KN van Munster","year":"2024","unstructured":"van Munster KN, Bergquist A, Ponsioen CY. Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two? J Hepatol. 2024;80:155\u2013168. https:\/\/doi.org\/10.1016\/j.jhep.2023.09.031.","journal-title":"J Hepatol."},{"key":"9593_CR5","doi-asserted-by":"publisher","unstructured":"Sleiman J, Francis FF, Coelho-Prabhu N, Hashash JG. All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease. Ann Gastroenterol. 2025 Mar-Apr;38(2):107\u2013120. https:\/\/doi.org\/10.20524\/aog.2025.0945. Epub 2025 Feb 25. PMID: 40124424; PMCID: PMC11928904.","DOI":"10.20524\/aog.2025.0945"},{"key":"9593_CR6","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","volume":"13","author":"SI Ilyas","year":"2015","unstructured":"Ilyas SI, Eaton JE, Gores GJ. Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management. Clin Gastroenterol Hepatol. 2015;13:2152\u20132165. https:\/\/doi.org\/10.1016\/j.cgh.2015.05.035.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR7","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","volume":"17","author":"CL Bowlus","year":"2019","unstructured":"Bowlus CL, Lim JK, Lindor KD. AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review. Clin Gastroenterol Hepatol. 2019;17:2416\u20132422. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR8","doi-asserted-by":"publisher","first-page":"1076788","DOI":"10.3389\/fgstr.2022.1076788","volume":"1","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Sagvand BT, Alizadeh M, Nguyen C, Scott W, von Rosenvinge EC. Primary sclerosing cholangitis and pancreatic cancer: a retrospective cohort study of United States veterans. Front Gastroenterol. 2023;1:1076788. https:\/\/doi.org\/10.3389\/fgstr.2022.1076788.","journal-title":"Front Gastroenterol."},{"key":"9593_CR9","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.24570","volume":"54","author":"N Razumilava","year":"2011","unstructured":"Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54:1842\u20131852. https:\/\/doi.org\/10.1002\/hep.24570.","journal-title":"Hepatology."},{"key":"9593_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","volume":"16","author":"SC Shah","year":"2018","unstructured":"Shah SC, ten Hove JR, Castaneda D et al. High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2018;16:1106-1113.e3. https:\/\/doi.org\/10.1016\/j.cgh.2018.01.023.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","volume":"110","author":"TA Brentnall","year":"1996","unstructured":"Brentnall TA, Haggitt RC, Rabinovitch PS et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331\u2013338. https:\/\/doi.org\/10.1053\/gast.1996.v110.pm8566577.","journal-title":"Gastroenterology."},{"key":"9593_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.1840220511","volume":"22","author":"U Broom\u00e9","year":"1995","unstructured":"Broom\u00e9 U, L\u00f6fberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995;22:1404\u20131408. https:\/\/doi.org\/10.1002\/hep.1840220511.","journal-title":"Hepatology."},{"key":"9593_CR13","doi-asserted-by":"publisher","unstructured":"Alsakarneh S, Aburumman R, Bilal M, Faye AS, Hashash JG, Shaukat A. Primary sclerosing cholangitis in the absence of inflammatory bowel disease increases the risk of colorectal cancer: A multi-centre propensity score matched analysis. Aliment Pharmacol Ther. Published online July 24, 2025. https:\/\/doi.org\/10.1111\/apt.70303","DOI":"10.1111\/apt.70303"},{"key":"9593_CR14","unstructured":"TriNetX. Accessed June 1, 2025. https:\/\/trinetx.com"},{"key":"9593_CR15","doi-asserted-by":"publisher","unstructured":"Alsakarneh S, Ahmed M, Azim S, Hashash JG, Farraye FA, Ghoz H. Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States. Am J Gastroenterol. 2024 Jul 25. https:\/\/doi.org\/10.14309\/ajg.0000000000002984. Epub ahead of print. PMID: 39051646.","DOI":"10.14309\/ajg.0000000000002984"},{"key":"9593_CR16","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.3748\/wjg.v20.i27.8783","volume":"20","author":"R Wang","year":"2014","unstructured":"Wang R, Leong RW. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature. World J Gastroenterol. 2014;20:8783\u20138789. https:\/\/doi.org\/10.3748\/wjg.v20.i27.8783.","journal-title":"World J Gastroenterol."},{"key":"9593_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","volume":"56","author":"RM Soetikno","year":"2002","unstructured":"Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointest Endosc. 2002;56:48\u201354. https:\/\/doi.org\/10.1067\/mge.2002.125367.","journal-title":"Gastrointest Endosc."},{"key":"9593_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus EV Jr, Harewood GC, Loftus CG et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91\u201396. https:\/\/doi.org\/10.1136\/gut.2004.046615.","journal-title":"Gut."},{"key":"9593_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","volume":"50","author":"MMH Claessen","year":"2009","unstructured":"Claessen MMH, Vleggaar FP, Tytgat KMAJ, Siersema PD, van Buuren HR. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol. 2009;50:158\u2013164. https:\/\/doi.org\/10.1016\/j.jhep.2008.08.013.","journal-title":"J Hepatol."},{"key":"9593_CR20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ibd.20886","volume":"15","author":"MMH Claessen","year":"2009","unstructured":"Claessen MMH, Lutgens MWMD, van Buuren HR et al. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis: a multicenter study. Inflamm Bowel Dis. 2009;15:1331\u20131336. https:\/\/doi.org\/10.1002\/ibd.20886.","journal-title":"Inflamm Bowel Dis."},{"key":"9593_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"KW Burak","year":"2004","unstructured":"Burak KW, Angulo P, Pasha TM et al. Incidence and risk factors for hepatobiliary cancer in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523\u2013526.","journal-title":"Am J Gastroenterol."},{"key":"9593_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/ajg.2016.55","volume":"111","author":"AF Gulamhusein","year":"2016","unstructured":"Gulamhusein AF, Eaton JE, Tabibian JH, Atkinson EJ, Juran BD, Lazaridis KN. Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD. Am J Gastroenterol. 2016;111:705\u2013711. https:\/\/doi.org\/10.1038\/ajg.2016.55.","journal-title":"Am J Gastroenterol."},{"key":"9593_CR23","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/003655202760373434","volume":"37","author":"KM Boberg","year":"2002","unstructured":"Boberg KM, Bergquist A, Mitchell S et al. Cholangiocarcinoma in primary sclerosing cholangitis: Risk factors and clinical presentation. Scand J Gastroenterol. 2002;37:1205\u20131211. https:\/\/doi.org\/10.1080\/003655202760373434.","journal-title":"Scand J Gastroenterol."},{"key":"9593_CR24","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.3748\/wjg.v24.i26.2844","volume":"24","author":"RS McCain","year":"2018","unstructured":"McCain RS, Diamond A, Jones C, Coleman HG. Current practices and future prospects for the management of gallbladder polyps: A topical review. World J Gastroenterol. 2018;24:2844\u20132852. https:\/\/doi.org\/10.3748\/wjg.v24.i26.2844.","journal-title":"World J Gastroenterol."},{"key":"9593_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00281-009-0154-7","volume":"31","author":"JH Aron","year":"2009","unstructured":"Aron JH, Bowlus CL. The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 2009;31:383\u2013397. https:\/\/doi.org\/10.1007\/s00281-009-0154-7.","journal-title":"Semin Immunopathol"},{"key":"9593_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","volume":"16","author":"N Krugliak Cleveland","year":"2018","unstructured":"Krugliak Cleveland N, Rubin DT, Hart J et al. Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon. Clin Gastroenterol Hepatol. 2018;16:68-75.e1. https:\/\/doi.org\/10.1016\/j.cgh.2017.07.023.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9593_CR27","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391:2547\u20132559. https:\/\/doi.org\/10.1016\/S0140-6736(18)30300-3.","journal-title":"Lancet."},{"key":"9593_CR28","doi-asserted-by":"publisher","unstructured":"Mikhail I, Al Ta\u2019ani O, Aburumman R, Alsakarneh S, Farraye FA, Hashash JG. Patients with Crohn\u2019s disease and terminal ileum resection are at increased risk of colorectal cancer: A population-based study. Inflamm Bowel Dis. Published online June 18, 2025. https:\/\/doi.org\/10.1093\/ibd\/izaf118","DOI":"10.1093\/ibd\/izaf118"},{"key":"9593_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","volume":"66","author":"MN Quraishi","year":"2017","unstructured":"Quraishi MN, Sergeant M, Kay G et al. The gut-adherent microbiota of PSC\u2013IBD is distinct to that of IBD. Gut. 2017;66:386\u2013388. https:\/\/doi.org\/10.1136\/gutjnl-2016-311915.","journal-title":"Gut."},{"key":"9593_CR30","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000615","volume":"14","author":"MH Wang","year":"2023","unstructured":"Wang MH, Friton JJ, Rebert N et al. Novel genetic risk variants and clinical predictors associated with primary sclerosing cholangitis in patients with ulcerative colitis. Clin Transl Gastroenterol. 2023;14:e00615. https:\/\/doi.org\/10.14309\/ctg.0000000000000615.","journal-title":"Clin Transl Gastroenterol."},{"key":"9593_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: Mechanisms and management. Gastroenterology. 2022;162:715\u2013730. https:\/\/doi.org\/10.1053\/j.gastro.2021.10.035.","journal-title":"Gastroenterology."},{"key":"9593_CR32","doi-asserted-by":"publisher","unstructured":"Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649\u2013670. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008","DOI":"10.1093\/ecco-jcc\/jjx008"},{"key":"9593_CR33","doi-asserted-by":"publisher","unstructured":"Hashash JG, Picco MF, Farraye FA. Health Maintenance for Adult Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2021;19(4):583\u2013596. https:\/\/doi.org\/10.1007\/s11938-021-00364-9. Epub 2021 Nov 22. PMID: 34840495; PMCID: PMC8608358.","DOI":"10.1007\/s11938-021-00364-9"},{"key":"9593_CR34","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-021-08384-w","volume":"32","author":"KG Foley","year":"2022","unstructured":"Foley KG, Lahaye MJ, Thoeni RF et al. Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES. EFISDS and ESGE. Eur Radiol 2022;32:3358\u20133368. https:\/\/doi.org\/10.1007\/s00330-021-08384-w.","journal-title":"EFISDS and ESGE. Eur Radiol"},{"key":"9593_CR35","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","volume":"52","author":"J Fevery","year":"2007","unstructured":"Fevery J, Verslype C, Lai G et al. Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. Dig Dis Sci 2007;52:3123\u20133135. https:\/\/doi.org\/10.1007\/s10620-006-9681-4.","journal-title":"Dig Dis Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09593-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09593-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:06:10Z","timestamp":1779685570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09593-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["9593"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09593-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}